Reduction of human Alzheimer's disease risk and reversal of mouse model cognitive deficit with nucleoside analog use
Magagnoli, J.; Yerramothu, P.; Ambati, K.; Cummings, T.; Nguyen, J.; Thomas, C.; Wang, S.-b.; Cheng, K.; Juraev, M.; Dholkawala, R.; Nagasaka, A.; Ambati, M.; Nagasaka, Y.; Ban, A.; Ambati, V.; Sutton, S. S.; Gelfand, B.; Ambati, J.
Show abstract
Innate immune signaling through the NLRP3 inflammasome has been implicated in the pathogenesis of Alzheimers disease (AD), the most prevalent form of dementia. We previously demonstrated that nucleoside reverse transcriptase inhibitors (NRTIs), drugs approved to treat HIV and hepatitis B infections, also inhibit inflammasome activation. Here we report that in humans, NRTI exposure was associated with a significantly lower incidence of AD in two of the largest health insurance databases in the United States. Treatment of aged 5xFAD mice (a mouse model of amyloid-{beta} deposition that expresses five mutations found in familial AD) with Kamuvudine-9 (K-9), an NRTI-derivative with enhanced safety profile, reduced A{beta} deposition and reversed their cognitive deficit by improving their spatial memory and learning performance to that of young wild-type mice. These findings support the concept that inflammasome inhibition could benefit AD and provide a rationale for prospective clinical testing of NRTIs or K-9 in AD.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Age, Sex and Alzheimer's disease: A longitudinal study of 3xTg-AD mice reveals sex-specific disease trajectories and inflammatory responses mirrored in postmortem brains from Alzheimer's patients 95%
- TREM2 Risk Variants with Alzheimer’s Disease Differ in Rate of Cognitive Decline 94%
- Selective agonism of GPR34 stimulates microglial uptake and clearance of amyloid β fibrils 94%
Similar papers in this journal
- Causal associations between potentially modifiable risk factors and the Alzheimer's phenome: A Mendelian randomization study 94%
- Contribution of genetic and environmental factors to the onset of preclinical Alzheimer's disease - a monozygotic twin study 91%
- Diet, pace of biological aging, and risk of dementia in the Framingham Heart Study 91%
Similar papers in this journal
- Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer's disease retina 95%
- Plasma p-tau212: antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology 94%
- Opposing roles of physiological and pathological amyloid-β on synapses in live human brain slice cultures 94%
Similar papers in this journal
- Tau-first subtype of Alzheimer's disease consistently identified across in vivo and post mortem studies 94%
- Selective vulnerability and resilience to Alzheimer's disease tauopathy as a function of genes and the connectome 93%
- Default mode network tau predicts future clinical decline in atypical early Alzheimer’s disease 93%